NFKB1 and carcinoma: We also noticed that in advanced stages of OC and in primary carcinoma tissues with metastatic potential, RONS can activate NF-κB activity by reducing the expression of its inhibitory protein (IκB) to promote inflammatory response (↑ TNFα).